NeoRx to invest in new Florida research center

Florida's new biotechnology research center, Scripps Florida, has inked a $2.5 million deal with Seattle based NeoRx to develop new cancer drugs. NeoRx gains the marketing rights to any drugs that are developed. Florida Gov. Jeb Bush calls it a sign of things to come.

- read this report from the Miami Herald for more

Suggested Articles

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.

The top-line readout appears to justify the risk the partners took when they advanced the drug despite missing the primary endpoint in phase 2.